Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $73084.0.

  • iSpecimen's Gains from Investment Securities rose 32475.88% to $73084.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $73084.0, marking a year-over-year increase of 32475.88%. This contributed to the annual value of $8460.0 for FY2024, which is 4288.8% down from last year.
  • iSpecimen's Gains from Investment Securities amounted to $73084.0 in Q3 2025, which was up 32475.88% from $72148.0 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Gains from Investment Securities ranged from a high of $351670.0 in Q2 2024 and a low of $15075.0 during Q3 2023
  • Moreover, its 5-year median value for Gains from Investment Securities was $171154.0 (2022), whereas its average is $200423.0.
  • In the last 5 years, iSpecimen's Gains from Investment Securities crashed by 9093.22% in 2023 and then skyrocketed by 32475.88% in 2025.
  • Quarter analysis of 5 years shows iSpecimen's Gains from Investment Securities stood at $165463.0 in 2021, then decreased by 0.81% to $164131.0 in 2022, then tumbled by 90.82% to $15075.0 in 2023, then grew by 14.14% to $17206.0 in 2024, then soared by 324.76% to $73084.0 in 2025.
  • Its Gains from Investment Securities stands at $73084.0 for Q3 2025, versus $72148.0 for Q2 2025 and $67224.0 for Q1 2025.